Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Mecánica aplicada
18
Estática
16
Dinámica
6
Literatura rusa
6
Análisis vectorial
5
Crítica e interpretación
5
Historia y crítica
4
Poesía rusa
4
Resistencia de materiales
4
Mecánica de fluidos
3
Problemas, ejercicios, etc
3
Teoría de las estructuras
3
Aerodinámica
2
Autores rusos
2
Canciones folklóricas mexicanas
2
Canciones infantiles
2
Control de vuelo
2
Cultura
2
Ensayos rusos
2
Estudio y enseñanza
2
Indígenas de México
2
Ingeniería mecánica
2
Modelos matemáticos
2
Método de elementos finitos
2
Novela hispanoamericana
2
Poesía colombiana
2
Poesía congoleña (Brazzaville)
2
Positivismo lógico
2
Robótica
2
Vida intelectual
2
-
38181por Riscili, Brent P., Anderson, Tyler B., Prescott, Hallie C., Exline, Matthew C., Sopirala, Madhuri M., Phillips, Gary S., Ali, Naeem A.“…First morning set tidal volumes and BMI were significantly associated with increased severity of lung injury (Lung injury score, LIS) at presentation and over time while prior prescription of statins was protective. After assessment of the effect of these co-interventions LIS was significantly higher in H1N1 patients. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
38182por Silverman, S. L., Kriegman, A., Goncalves, J., Kianifard, F., Carlson, T., Leary, E.“…The cause is unknown but may be related to transient cytokine elevations. Statins’ potential to block release of these cytokines has been hypothesized. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38183por Dalmau, Rosa, Boira, Miriam, Aguilar, Carina, López, Carlos, Rodríguez, Dolors, Gentille, Delicia, Bofill, Domingo, Diogene, Eduard, Pepió, Josep M“…BACKGROUND: Cardiovascular diseases(CVD), specifically ischaemic heart disease(IHD), are the main causes of death in industrialized countries. Statins are not usually prescribed in the most appropriate way. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38184por Di Marco, Giovana S., Rustemeyer, Peter, Brand, Marcus, Koch, Raphael, Kentrup, Dominik, Grabner, Alexander, Greve, Burkhard, Wittkowski, Werner, Pavenstädt, Hermann, Hausberg, Martin, Reuter, Stefan, Lang, Detlef“…There were no correlations between EPC levels and statin, erythropoietin or use of renin angiotensin system blockers in our study. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38185por Bansal, Nisha, Hsu, Chi-yuan, Chandra, Malini, Iribarren, Carlos, Fortmann, Stephen P, Hlatky, Mark A, Go, Alan S“…After further adjustment for statins, β-blocker, calcium channel blocker, ACE inhibitor/ARB use, the association was no longer significant for eGFR 45-59 ml/min/1.73 m(2 )(HR 0.82, 95% CI: 0.25 to 2.66) or for eGFR < 45 ml/min/1.73 m(2 )(HR 1.19, 95% CI: 0.25 to 5.58). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38186por Boggon, Rachael, van Staa, Tjeerd P., Timmis, Adam, Hemingway, Harry, Ray, Kausik K., Begg, Alan, Emmas, Cathy, Fox, Keith A.A.“…The adjusted odds of still being prescribed clopidogrel at 12 months were similar following non-ST-elevation myocardial infarction (NSTEMI) 53% (95% CI, 51–55) and ST-elevation myocardial infarction (STEMI) 54% (95% CI, 52–56), but contrast with statins: NSTEMI 84% (95% CI, 82–85) and STEMI 89% (95% CI, 87–90). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38187por Hing Ling, Paul Kah, Civeira, Fernando, Dan, Andrei Gheorghe, Hanson, Mary E, Massaad, Rachid, De Tilleghem, Celine Le Bailly, Milardo, Christopher, Triscari, Joseph“…BACKGROUND: A considerable number of patients with severely elevated LDL-C do not achieve recommended treatment targets, despite treatment with statins. Adults at high cardiovascular risk with hypercholesterolemia and LDL-C ≥ 2.59 and ≤ 4.14 mmol/L (N = 250), pretreated with atorvastatin 20 mg were randomized to ezetimibe/simvastatin 10/40 mg or atorvastatin 40 mg for 6 weeks. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38188por Matsuda, Morihiro, Akizuki, Manami, Nishimoto, Orie, Nakamoto, Kei, Nishiyama, Hirohiko, Tamura, Ritsu, Kawamoto, Toshiharu“…At the 12-month visit, prescription rates for anti-platelet drugs, statins, β-blockers, and angiotensin-converting enzyme inhibitors or angiotensin II type I receptor blockers were 99.7%, 95.0%, 77.1%, and 74.3%, respectively. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38189por Bresson, Eva, Lacroix-Pépin, Nicolas, Boucher-Kovalik, Sofia, Chapdelaine, Pierre, Fortier, Michel A.“…We also show that AKR1B1 is able to regulate PGE2 production through PGF2α acting on its FP receptor and that aldose reductase inhibitors like alrestatin, Statil (ponalrestat), and EBPC exhibit distinct and characteristic inhibition of PGF2α production in different cell models. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38190“…CONCLUSIONS: Concomitant administration of simvastatin with ivabradine intensified slowing of HR, although it did not influence BP in normo-and hypercholesterolemic rats. Statin-induced intensification of HR deceleration after metoprolol administration was not observed.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38191“…BACKGROUND: Although statins (STs) are drugs of first choice in hypercholesterolemic patients, especially in those at high cardiovascular risk, some of them are intolerant to STs or refuse treatment with these drugs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38192por McLernon, David J., Dillon, John F., Sullivan, Frank M., Roderick, Paul, Rosenberg, William M., Ryder, Stephen D., Donnan, Peter T.“…Predictors of mortality included: age; male gender; social deprivation; history of cancer, renal disease, stroke, ischaemic heart disease or respiratory disease; statin use; and LFTs (albumin, transaminase, alkaline phosphatase, bilirubin, and gamma-glutamyltransferase). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38193por Azrad, Maria, Zhang, Kui, Vollmer, Robin T., Madden, John, Polascik, Thomas J., Snyder, Denise C., Ruffin, Mack T., Moul, Judd W., Brenner, Dean, Hardy, Robert W., Demark-Wahnefried, Wendy“…After adjusting for covariates (flaxseed, age, race, BMI and statin-use) the association between ALA and PSA remained (p = 0.004) but was slightly attenuated for Ki67 (p = 0.051). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38194por Shehab, Abdulla, Al-Dabbagh, Bayan, AlHabib, Khalid F., Alsheikh-Ali, Alawi A., Almahmeed, Wael, Sulaiman, Kadhim, Al-Motarreb, Ahmed, Nagelkerke, Nicolaas, Suwaidi, Jassim Al, Hersi, Ahmad, Faleh, Hussam Al, Asaad, Nidal, Saif, Shukri Al, Amin, Haitham“…Fewer women than men received angiotensin-converting enzyme inhibitors (ACE), aspirin, clopidogrel, beta blockers or statins at discharge. They also underwent fewer invasive procedures including angiography (27.0% vs. 34.0%; P<0.001), percutaneous coronary intervention (PCI) (10.5% vs. 15.6%; P<0.001) and reperfusion therapy (6.9% vs. 20.2%; P<0.001) than men. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38195por Marrs, Joel C.“…Colesevelam was not associated with weight gain, was associated with a low incidence of hypoglycaemia, and can be safely combined with a broad range of glucose-lowering agents (metformin, sulfonylureas and insulin) and lipid-lowering statins. Currently, colesevelam is available in tablet form and as a powder for oral suspension formulation; the latter may be of benefit to elderly patients with swallowing difficulties. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38196por Ayaori, Makoto, Iwakami, Naotsugu, Uto‐Kondo, Harumi, Sato, Hiroki, Sasaki, Makoto, Komatsu, Tomohiro, Iizuka, Maki, Takiguchi, Shunichi, Yakushiji, Emi, Nakaya, Kazuhiro, Yogo, Makiko, Ogura, Masatsune, Takase, Bonpei, Murakami, Takehiko, Ikewaki, Katsunori“…Interestingly, FMD reduction was less evident in subjects who were on statins or whose LDL cholesterol levels were reduced by them, but this was not correlated with parameters including DPP‐4 activity and GLP‐1 levels or diabetic parameters. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38197“…These effects are substantially larger than would be achieved through aspirin, antihypertensive, and statin therapy under most scenarios, because of limited treatment access and adherence; nevertheless, the impacts of tobacco control policies and pharmacological interventions appear to be markedly synergistic, averting up to one-third of deaths from myocardial infarction and stroke among 20- to 79-y-olds over the next 10 y. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38198“…METHODS: We performed a blinded, randomized hypothesis generating study in human subjects (n=12) treated sequentially with statins of differing potencies to vary lipid levels. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38199por Oh, Pyung Chun, Choi, In Suck, Ahn, Taehoon, Moon, Jeonggeun, Park, Yeonjeong, Seo, Jong Goo, Suh, Soon Yong, Ahn, Youngkeun, Jeong, Myung Ho“…In addition, the use of statin was independently associated with a recovery of LV systolic dysfunction {OR (95% CI), 1.46 (1.07-2.00)}. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38200por Klop, Boudewijn, van de Geijn, Gert-Jan M., Bovenberg, Sarah A., van der Meulen, Noëlle, Elte, Jan Willem F., Birnie, Erwin, Njo, Tjin L., Janssen, Hans W., van Miltenburg, Addy, Jukema, J. Wouter, Cabezas, Manuel Castro“…A total of 55 subjects (13.6%) were considered ery-apoB deficient, which was associated with a medical history of CVD (OR: 1.86, 95% CI 1.04–3.33; adjusted OR: 1.55; 95% CI 0.85–2.82). Discontinuation of statins in 54 subjects did not influence ery-apoB values despite a 58.4% increase in serum apolipoprotein B. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto